Shares of ValiRx plc (LON:VAL – Get Free Report) were up 13.5% on Wednesday . The company traded as high as GBX 0.88 ($0.01) and last traded at GBX 0.88 ($0.01). Approximately 8,830,195 shares changed hands during mid-day trading, a decline of 62% from the average daily volume of 23,453,170 shares. The stock had previously closed at GBX 0.78 ($0.01).
ValiRx Stock Performance
The company has a 50-day moving average of GBX 1.07 and a 200-day moving average of GBX 1.71. The company has a market cap of £1.10 million, a PE ratio of -41.60 and a beta of 0.59. The company has a quick ratio of 1.27, a current ratio of 6.65 and a debt-to-equity ratio of 0.49.
About ValiRx
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
Further Reading
- Five stocks we like better than ValiRx
- 5 Top Rated Dividend Stocks to Consider
- SAP’s Strong Momentum: A Bullish Setup for Investors
- Do ETFs Pay Dividends? What You Need to Know
- BlackRock Breaks Records: Why the Stock Still Has Room to Run
- Investing In Automotive Stocks
- Duke vs. NRG: Which Energy Stock Will Power Higher Gains?
Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.
